Previous close | 2.0000 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 330.00 |
Expiry date | 2024-07-19 |
Day's range | 2.0000 - 2.0000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Here is how Avery Dennison (AVY) and Encore Wire (WIRE) have performed compared to their sector so far this year.